SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-18-000054
Filing Date
2018-06-25
Accepted
2018-06-25 17:12:36
Documents
4
Period of Report
2018-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca_8kx6x25x18.htm 8-K 41041
2 EXHIBIT 3.1 gnca625188kex31.htm EX-3.1 9613
3 EXHIBIT 10.1 gnca625188kex101.htm EX-10.1 87973
4 EXHIBIT 10.2 gnca625188kex102.htm EX-10.2 55182
  Complete submission text file 0001457612-18-000054.txt   195254
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 18917670
SIC: 2836 Biological Products, (No Diagnostic Substances)